V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240015480 | 240009003 | 1.63 | 64.5 | Curative (C) | null | 2017-01-11 | CYTARABINE + METHOTREXATE + RITUXIMAB | N | N | 240004804 | CARBOPLATIN + LIPOSOMAL DOX |
| 240015481 | 240009005 | 1.81 | 65.4 | Palliative (P) | 2016-08-21 | 2018-04-05 | Cytarabine High Dose | 01 | N | 240006774 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240015482 | 240009007 | 1.74 | 63 | Curative (C) | 2018-11-10 | 2018-11-23 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 02 | N | 240007272 | DHAP - R |
| 240015483 | 240012816 | 1.64 | 47 | Palliative (P) | 2017-11-05 | 2017-11-05 | MABCUTE TRIAL | 02 | N | 240012412 | CISPLATIN + GEMCITABINE |
| 240015484 | 240009014 | 1.83 | 85.2 | Curative (C) | 2016-09-05 | 2016-09-12 | AML17 TRIAL | 1 | N | 240015382 | R CODOX-M/ R IVAC |
| 240015485 | 240014598 | 1.74 | 65 | Palliative (P) | 2014-06-30 | 2014-07-03 | R CODOX-M/ R IVAC | 01 | N | 240016293 | CARMUSTINE + THIOTEPA |
| 240015486 | 240009025 | 1.52 | null | Disease modification (D) | 2016-04-20 | 2017-11-23 | Ixazomib + Lenalidomide | 02 | N | 240022190 | TOPOTECAN |
| 240015487 | 240009030 | 1.56 | 76.4 | Curative (C) | 2016-05-19 | 2016-05-20 | REMODLB TRIAL | 2 | N | 240023588 | IVE-R |
| 240015488 | 240009035 | null | 69 | Palliative (P) | null | 2019-08-17 | AML16 DA 3+10 | N | N | 240034505 | ACE |
| 240015489 | 240012827 | 1.57 | 100.8 | Palliative (P) | 2017-11-06 | 2018-01-10 | ALL UKALL60+ TRIAL | N | N | 240015030 | CAPECITABINE + OXALIPLATIN |
| 240015490 | 240011017 | 1.52 | 100 | Palliative (P) | 2015-11-26 | 2015-11-28 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 240000030 | RITUXIMAB |
| 240015491 | 240014992 | null | null | Curative (C) | 2016-02-11 | 2016-04-10 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 240000092 | RITUXIMAB |
| 240015492 | 240015676 | 1.55 | 78.1 | Disease modification (D) | null | 2018-03-05 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 240000135 | RITUXIMAB |
| 240015493 | 240005523 | 1.64 | null | Not known (9) | 2016-07-13 | 2017-01-14 | Rituximab | N | N | 240000246 | RITUXIMAB |
| 240015494 | 240005530 | 1.6 | 47.6 | Adjuvant (A) | 2018-09-07 | 2018-09-16 | Rituximab | 2 | N | 240000300 | RITUXIMAB |
| 240015495 | 240005535 | 1.54 | 100.5 | Palliative (P) | 2016-03-08 | 2016-03-10 | Rituximab | 02 | N | 240000359 | RITUXIMAB |
| 240015496 | 240005557 | 1.61 | 56 | Curative (C) | 2016-11-17 | 2016-12-20 | Rituximab (Maintenance) | 02 | N | 240000605 | RITUXIMAB |
| 240015497 | 240005567 | 1.8 | 106.8 | Curative (C) | 2018-03-10 | 2019-01-02 | Rituximab | N | N | 240000683 | RITUXIMAB |
| 240015498 | 240005579 | null | 54.5 | Disease modification (D) | 2019-03-19 | 2019-04-22 | Rituximab | 2 | N | 240000788 | RITUXIMAB |
| 240015499 | 240005586 | 1.57 | 55 | Disease modification (D) | 2013-01-01 | 2014-07-28 | Rituximab (Maintenance) | N | N | 240000835 | RITUXIMAB |
| 240015500 | 240005609 | 1.74 | null | Disease modification (D) | 2015-10-03 | 2015-10-09 | Rituximab | N | Y | 240001065 | RITUXIMAB |
| 240015502 | 240014999 | null | 0 | Palliative (P) | 2018-10-09 | 2019-03-16 | Rituximab (Maintenance) | null | null | 240001315 | RITUXIMAB |
| 240015503 | 240011070 | null | null | Palliative (P) | 2014-02-08 | 2015-12-17 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 240001416 | RITUXIMAB |
| 240015504 | 240011071 | 1.56 | 69 | Curative (C) | null | 2018-08-21 | Rituximab | N | N | 240001458 | RITUXIMAB |
| 240015505 | 240011073 | 1.62 | 57 | Curative (C) | 2016-12-19 | 2017-05-04 | Rituximab | N | N | 240001507 | RITUXIMAB |
| 240015506 | 240005655 | 1.6 | 59.7 | Disease modification (D) | 2018-04-05 | 2018-04-07 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 240001762 | RITUXIMAB |
| 240015507 | 240005659 | 1.54 | null | Disease modification (D) | 2017-12-19 | 2019-02-15 | Rituximab | 02 | N | 240001843 | RITUXIMAB |
| 240015508 | 240005679 | null | 69 | Adjuvant (A) | 2018-01-30 | 2019-02-22 | Rituximab (Maintenance) | N | N | 240002151 | RITUXIMAB |
| 240015509 | 240005683 | 1.63 | 64.8 | Disease modification (D) | 2014-07-16 | 2015-03-09 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 240002280 | RITUXIMAB |
| 240015510 | 240011113 | 1.8 | 94 | Adjuvant (A) | 2015-08-21 | 2015-08-24 | Rituximab | N | N | 240002899 | RITUXIMAB |
| 240015511 | 240005719 | 1.68 | 64.2 | null | 2015-09-24 | 2015-10-06 | Rituximab | N | N | 240002950 | RITUXIMAB |
| 240015512 | 240013721 | 1.71 | 89 | Curative (C) | 2017-09-22 | 2017-09-22 | Rituximab (Maintenance) | 02 | N | 240003131 | RITUXIMAB |
| 240015513 | 240005737 | 1.61 | 60.8 | Not known (9) | 2019-04-24 | 2019-06-03 | Rituximab | 2 | N | 240003154 | RITUXIMAB |
| 240015514 | 240005742 | 1.6 | null | Curative (C) | 2017-03-31 | 2017-05-09 | Rituximab | N | N | 240003377 | RITUXIMAB |
| 240015515 | 240005764 | 1.7 | 96.3 | Disease modification (D) | 2016-03-09 | 2017-01-05 | Rituximab | N | N | 240003876 | RITUXIMAB |
| 240015516 | 240005768 | 1.49 | null | Curative (C) | 2019-02-18 | 2019-02-27 | Rituximab | N | null | 240003885 | RITUXIMAB |
| 240015517 | 240005774 | null | 93 | Not known (9) | 2019-01-03 | 2019-01-03 | Rituximab | 02 | N | 240004078 | RITUXIMAB |
| 240015518 | 240011140 | 1.7 | 72.8 | Curative (C) | 2015-07-10 | 2015-08-25 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 240004135 | RITUXIMAB |
| 240015519 | 240005783 | 1.6 | 0 | Disease modification (D) | 2018-10-02 | 2018-10-02 | Rituximab | 02 | N | 240004269 | RITUXIMAB |
| 240015520 | 240005787 | 1.68 | null | null | 2019-06-22 | 2019-07-21 | Rituximab (Maintenance) | N | N | 240004290 | RITUXIMAB |
| 240015521 | 240005808 | 1.79 | 87 | Disease modification (D) | 2015-08-25 | 2015-09-02 | Rituximab | 02 | N | 240004511 | RITUXIMAB |
| 240015522 | 240011163 | 1.69 | 50 | Palliative (P) | 2018-11-21 | 2018-12-27 | Rituximab (Maintenance) | N | N | 240004902 | RITUXIMAB |
| 240015523 | 240005834 | 1.67 | null | Adjuvant (A) | 2015-07-21 | 2016-01-28 | Rituximab | N | N | 240004959 | RITUXIMAB |
| 240015524 | 240005879 | 1.69 | 61.2 | Disease modification (D) | 2018-09-02 | 2018-10-21 | Rituximab | 02 | N | 240005730 | RITUXIMAB |
| 240015525 | 240005886 | 1.53 | null | Disease modification (D) | 2016-02-26 | 2016-09-25 | Rituximab | N | N | 240005788 | RITUXIMAB |
| 240015526 | 240005914 | 1.68 | 58 | Curative (C) | 2014-02-18 | 2014-09-22 | Rituximab | 02 | N | 240006095 | RITUXIMAB |
| 240015527 | 240011218 | 1.52 | 74 | Curative (C) | 2017-01-27 | 2017-02-22 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 240006303 | RITUXIMAB |
| 240015528 | 240005953 | null | 63.4 | Curative (C) | 2013-12-08 | 2014-12-05 | Rituximab | N | N | 240006533 | RITUXIMAB |
| 240015529 | 240005972 | 1.67 | null | Palliative (P) | 2018-01-11 | 2018-01-12 | Rituximab | 02 | N | 240006834 | RITUXIMAB |
| 240015530 | 240005975 | 1.71 | 43.6 | Curative (C) | null | 2014-06-12 | Rituximab | N | N | 240006843 | RITUXIMAB |